These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 37940562)

  • 1. A Network Model of the Modulation of γ Oscillations by NMDA Receptors in Cerebral Cortex.
    Susin E; Destexhe A
    eNeuro; 2023 Nov; 10(11):. PubMed ID: 37940562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketamine induced converged synchronous gamma oscillations in the cortico-basal ganglia network of nonhuman primates.
    Slovik M; Rosin B; Moshel S; Mitelman R; Schechtman E; Eitan R; Raz A; Bergman H
    J Neurophysiol; 2017 Aug; 118(2):917-931. PubMed ID: 28468999
    [No Abstract]   [Full Text] [Related]  

  • 3. Complex receptor mediation of acute ketamine application on in vitro gamma oscillations in mouse prefrontal cortex: modeling gamma band oscillation abnormalities in schizophrenia.
    McNally JM; McCarley RW; McKenna JT; Yanagawa Y; Brown RE
    Neuroscience; 2011 Dec; 199():51-63. PubMed ID: 22027237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMDA receptor hypofunction leads to generalized and persistent aberrant gamma oscillations independent of hyperlocomotion and the state of consciousness.
    Hakami T; Jones NC; Tolmacheva EA; Gaudias J; Chaumont J; Salzberg M; O'Brien TJ; Pinault D
    PLoS One; 2009 Aug; 4(8):e6755. PubMed ID: 19707548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-methyl d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex.
    Pinault D
    Biol Psychiatry; 2008 Apr; 63(8):730-5. PubMed ID: 18022604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential role of NR2A and NR2B subunits in N-methyl-D-aspartate receptor antagonist-induced aberrant cortical gamma oscillations.
    Kocsis B
    Biol Psychiatry; 2012 Jun; 71(11):987-95. PubMed ID: 22055014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of thalamo-cortical activity by the NMDA receptor antagonists ketamine and phencyclidine in the awake freely-moving rat.
    Amat-Foraster M; Celada P; Richter U; Jensen AA; Plath N; Artigas F; Herrik KF
    Neuropharmacology; 2019 Nov; 158():107745. PubMed ID: 31445017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of acute and chronic administration of ketamine on hippocampal oscillations: relevance for the NMDA receptor hypofunction model of schizophrenia.
    Kittelberger K; Hur EE; Sazegar S; Keshavan V; Kocsis B
    Brain Struct Funct; 2012 Apr; 217(2):395-409. PubMed ID: 21979451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant alpha and gamma oscillations ex vivo after single application of the NMDA receptor antagonist MK-801.
    Lemercier CE; Holman C; Gerevich Z
    Schizophr Res; 2017 Oct; 188():118-124. PubMed ID: 28109667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine Alters Lateral Prefrontal Oscillations in a Rule-Based Working Memory Task.
    Ma L; Skoblenick K; Johnston K; Everling S
    J Neurosci; 2018 Mar; 38(10):2482-2494. PubMed ID: 29437929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine Dysregulates the Amplitude and Connectivity of High-Frequency Oscillations in Cortical-Subcortical Networks in Humans: Evidence From Resting-State Magnetoencephalography-Recordings.
    Rivolta D; Heidegger T; Scheller B; Sauer A; Schaum M; Birkner K; Singer W; Wibral M; Uhlhaas PJ
    Schizophr Bull; 2015 Sep; 41(5):1105-14. PubMed ID: 25987642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memantine and Ketamine Differentially Alter NMDA Receptor Desensitization.
    Glasgow NG; Povysheva NV; Azofeifa AM; Johnson JW
    J Neurosci; 2017 Oct; 37(40):9686-9704. PubMed ID: 28877967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GluN2D N-Methyl-d-Aspartate Receptor Subunit Contribution to the Stimulation of Brain Activity and Gamma Oscillations by Ketamine: Implications for Schizophrenia.
    Sapkota K; Mao Z; Synowicki P; Lieber D; Liu M; Ikezu T; Gautam V; Monaghan DT
    J Pharmacol Exp Ther; 2016 Mar; 356(3):702-11. PubMed ID: 26675679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMDA receptors containing GluN2C and GluN2D subunits have opposing roles in modulating neuronal oscillations; potential mechanism for bidirectional feedback.
    Mao Z; He S; Mesnard C; Synowicki P; Zhang Y; Chung L; Wiesman AI; Wilson TW; Monaghan DT
    Brain Res; 2020 Jan; 1727():146571. PubMed ID: 31786200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological manipulation of the olfactory bulb modulates beta oscillations: testing model predictions.
    Osinski BL; Kim A; Xiao W; Mehta NM; Kay LM
    J Neurophysiol; 2018 Sep; 120(3):1090-1106. PubMed ID: 29847235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The psychotomimetic ketamine disrupts the transfer of late sensory information in the corticothalamic network.
    Qin Y; Mahdavi A; Bertschy M; Anderson PM; Kulikova S; Pinault D
    Eur J Neurosci; 2023 Feb; 57(3):440-455. PubMed ID: 36226598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute administration of typical and atypical antipsychotics reduces EEG γ power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in γ power.
    Jones NC; Reddy M; Anderson P; Salzberg MR; O'Brien TJ; Pinault D
    Int J Neuropsychopharmacol; 2012 Jun; 15(5):657-68. PubMed ID: 21733235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporally dissociable effects of ketamine on neuronal discharge and gamma oscillations in rat thalamo-cortical networks.
    Amat-Foraster M; Jensen AA; Plath N; Herrik KF; Celada P; Artigas F
    Neuropharmacology; 2018 Jul; 137():13-23. PubMed ID: 29702122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain NMDA Receptors in Schizophrenia and Depression.
    Adell A
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32585886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The N-Methyl d-Aspartate Glutamate Receptor Antagonist Ketamine Disrupts the Functional State of the Corticothalamic Pathway.
    Anderson PM; Jones NC; O'Brien TJ; Pinault D
    Cereb Cortex; 2017 Jun; 27(6):3172-3185. PubMed ID: 27261525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.